194 related articles for article (PubMed ID: 22832660)
1. Tolfenamic acid suppresses cytochrome P450 2E1 expression in mouse liver.
Shukoor MI; Tiwari S; Sankpal UT; Maliakal P; Connelly SF; Siddiqi S; Siddiqi SA; Basha R
Integr Biol (Camb); 2012 Sep; 4(9):1122-9. PubMed ID: 22832660
[TBL] [Abstract][Full Text] [Related]
2. Cytochrome P4502E1 induction increases thioacetamide liver injury in diet-restricted rats.
Ramaiah SK; Apte U; Mehendale HM
Drug Metab Dispos; 2001 Aug; 29(8):1088-95. PubMed ID: 11454726
[TBL] [Abstract][Full Text] [Related]
3. Chemopreventive effects of tolfenamic acid against esophageal tumorigenesis in rats.
Maliakal P; Abdelrahim M; Sankpal UT; Maliakal C; Baker CH; Safe S; Herrera LJ; Abudayyeh A; Kaja S; Basha R
Invest New Drugs; 2012 Jun; 30(3):853-61. PubMed ID: 21197621
[TBL] [Abstract][Full Text] [Related]
4. Small molecule tolfenamic acid inhibits PC-3 cell proliferation and invasion in vitro, and tumor growth in orthotopic mouse model for prostate cancer.
Sankpal UT; Abdelrahim M; Connelly SF; Lee CM; Madero-Visbal R; Colon J; Smith J; Safe S; Maliakal P; Basha R
Prostate; 2012 Nov; 72(15):1648-58. PubMed ID: 22473873
[TBL] [Abstract][Full Text] [Related]
5. Narcotic drugs change the expression of cytochrome P450 2E1 and 2C6 and other activities of carcinogen-metabolizing enzymes in the liver of male mice.
Sheweita SA
Toxicology; 2003 Sep; 191(2-3):133-42. PubMed ID: 12965116
[TBL] [Abstract][Full Text] [Related]
6. Anticancer activity of tolfenamic acid in medulloblastoma: a preclinical study.
Eslin D; Lee C; Sankpal UT; Maliakal P; Sutphin RM; Abraham L; Basha R
Tumour Biol; 2013 Oct; 34(5):2781-9. PubMed ID: 23686785
[TBL] [Abstract][Full Text] [Related]
7. Effect of ethanol treatment on metabolic activation and detoxification of esophagus carcinogenic N-nitrosamines in rat liver.
Mori Y; Koide A; Kobayashi Y; Morimura K; Kaneko M; Fukushima S
Mutagenesis; 2002 May; 17(3):251-6. PubMed ID: 11971997
[TBL] [Abstract][Full Text] [Related]
8. Oxidation of 1,2-epoxy-3-butene to 1,2:3,4-diepoxybutane by cDNA-expressed human cytochromes P450 2E1 and 3A4 and human, mouse and rat liver microsomes.
Seaton MJ; Follansbee MH; Bond JA
Carcinogenesis; 1995 Oct; 16(10):2287-93. PubMed ID: 7586124
[TBL] [Abstract][Full Text] [Related]
9. Anti-leukemic response of a NSAID, tolfenamic acid.
Sutphin RM; Connelly SF; Lee CM; Sankpal UT; Eslin D; Khan M; Pius H; Basha R
Target Oncol; 2014 Jun; 9(2):135-44. PubMed ID: 23609055
[TBL] [Abstract][Full Text] [Related]
10. Differential in vivo effects of alpha-naphthoflavone and beta-naphthoflavone on CYP1A1 and CYP2E1 in rat liver, lung, heart, and kidney.
Sinal CJ; Webb CD; Bend JR
J Biochem Mol Toxicol; 1999; 13(1):29-40. PubMed ID: 9890445
[TBL] [Abstract][Full Text] [Related]
11. Suppression of rat hepatic cytochrome P450 2E1 expression by isopropyl 2-(1,3-dithioetane-2-ylidene)-2-[N-(4-methyl-thiazol-2-yl)carbamoyl] acetate (YH439), an experimental hepatoprotectant: protective role against hepatic injury.
Choi EY; Kim SG; Lee JW; Yoo JK; Shin JK; Kim ND
Biochem Pharmacol; 1996 Oct; 52(8):1219-25. PubMed ID: 8937429
[TBL] [Abstract][Full Text] [Related]
12. Tolfenamic acid inhibits esophageal cancer through repression of specificity proteins and c-Met.
Papineni S; Chintharlapalli S; Abdelrahim M; Lee SO; Burghardt R; Abudayyeh A; Baker C; Herrera L; Safe S
Carcinogenesis; 2009 Jul; 30(7):1193-201. PubMed ID: 19406933
[TBL] [Abstract][Full Text] [Related]
13. Ethanol increases mitochondrial cytochrome P450 2E1 in mouse liver and rat hepatocytes.
Robin MA; Sauvage I; Grandperret T; Descatoire V; Pessayre D; Fromenty B
FEBS Lett; 2005 Dec; 579(30):6895-902. PubMed ID: 16337197
[TBL] [Abstract][Full Text] [Related]
14. Alkylation of cellular macromolecules and target specificity of carcinogenic nitrosodialkylamines: metabolic activation by cytochromes P450 2B1 and 2E1.
Shu L; Hollenberg PF
Carcinogenesis; 1997 Apr; 18(4):801-10. PubMed ID: 9111218
[TBL] [Abstract][Full Text] [Related]
15. Renal tumorigenicity of 1,1-dichloroethene in mice: the role of male-specific expression of cytochrome P450 2E1 in the renal bioactivation of 1,1-dichloroethene.
Speerschneider P; Dekant W
Toxicol Appl Pharmacol; 1995 Jan; 130(1):48-56. PubMed ID: 7839370
[TBL] [Abstract][Full Text] [Related]
16. Potentiation of thioacetamide liver injury in diabetic rats is due to induced CYP2E1.
Wang T; Shankar K; Ronis MJ; Mehendale HM
J Pharmacol Exp Ther; 2000 Aug; 294(2):473-9. PubMed ID: 10900221
[TBL] [Abstract][Full Text] [Related]
17. Role of CYP2E1 and saturation kinetics in the bioactivation of thioacetamide: Effects of diet restriction and phenobarbital.
Chilakapati J; Korrapati MC; Shankar K; Hill RA; Warbritton A; Latendresse JR; Mehendale HM
Toxicol Appl Pharmacol; 2007 Feb; 219(1):72-84. PubMed ID: 17234228
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of rat and human cytochrome P4502E1 catalytic activity and reactive oxygen radical formation by nitric oxide.
Gergel D; MisÃk V; Riesz P; Cederbaum AI
Arch Biochem Biophys; 1997 Jan; 337(2):239-50. PubMed ID: 9016819
[TBL] [Abstract][Full Text] [Related]
19. The regulation of cytochrome P450 2E1 during LPS-induced inflammation in the rat.
Abdulla D; Goralski KB; Renton KW
Toxicol Appl Pharmacol; 2006 Oct; 216(1):1-10. PubMed ID: 16712892
[TBL] [Abstract][Full Text] [Related]
20. Human cytochrome P450 isozymes in metabolism and health effects of gasoline ethers.
Hong JY; Wang YY; Mohr SN; Bondoc FY; Deng C
Res Rep Health Eff Inst; 2001 May; (102):7-27; discussion 95-109. PubMed ID: 11504148
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
